{"gene":"CYBB","run_date":"2026-06-09T22:57:19","timeline":{"discoveries":[{"year":1998,"finding":"gp91(phox) is the sole heme-binding subunit of flavocytochrome b558. COS7 cells expressing gp91(phox) alone showed a b-type cytochrome spectrum identical to neutrophil flavocytochrome b558, with two heme groups at midpoint potentials of -264 and -233 mV. p22(phox) alone showed no heme spectrum. However, coexpression of both subunits was required to reconstitute O2- production with neutrophil cytosol, indicating both subunits are necessary for functional NADPH oxidase assembly.","method":"Transgenic COS7 cell expression, spectral analysis, redox titration, confocal microscopy, immunoblotting of subcellular fractions, cell-free superoxide production assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with spectral and redox titration plus mutagenesis-level subunit dissection; multiple orthogonal methods in single rigorous study","pmids":["9653128"],"is_preprint":false},{"year":1995,"finding":"gp91-phox and p22-phox form a 1:1 stoichiometric heterodimer in cytochrome b558. Direct N-terminal peptide sequencing of affinity-purified cytochrome b558 from human neutrophil membranes yielded a p22-phox:gp91-phox amino acid ratio of 0.96 ± 0.05, consistent with a 1:1 stoichiometry.","method":"Affinity purification of cytochrome b558 from neutrophil membranes, direct N-terminal peptide sequencing with quantitative amino acid analysis","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct biochemical sequencing of purified native complex with quantitative analysis across 25 cycles and 8 amino acids","pmids":["8527449"],"is_preprint":false},{"year":2008,"finding":"gp91phox/NOX2 is phosphorylated by protein kinase C (PKC) in stimulated human neutrophils. PKC phosphorylates the cytosolic carboxy-terminal flavoprotein domain of gp91phox on the same peptides phosphorylated in intact cells. PKC phosphorylation enhances the diaphorase activity of the gp91phox flavoprotein domain and increases its binding to Rac2, p67phox, and p47phox, thereby enhancing NADPH oxidase complex assembly and catalytic activity.","method":"2D tryptic peptide mapping, in vitro PKC phosphorylation of recombinant gp91phox cytosolic domain, diaphorase activity assay, binding assays with Rac2/p67phox/p47phox, PKC inhibitor (GF109203X) in intact neutrophils, CGD patient controls","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro phosphorylation with recombinant domain, 2D peptide mapping, functional diaphorase assay, confirmed in intact cells with inhibitor and CGD patient negative controls; multiple orthogonal methods","pmids":["19028840"],"is_preprint":false},{"year":2000,"finding":"Four missense mutations in gp91phox (Cys369Arg, Gly408Glu, Glu568Lys, Thr341Lys) identified in X-CGD patients abolish NADPH oxidase activity. Mutations at residues 369, 408, and 568 strongly impaired translocation/binding of p47phox and p67phox to the membrane cytochrome b558 in stimulated neutrophils and cell-free translocation assay. The Thr341Lys substitution (in the FAD-binding domain) supported normal p47phox/p67phox translocation but abolished electron transfer, implicating this residue in hydride transfer from NADPH to FAD. All four substitutions eliminated electron transfer in solubilized plasma membranes.","method":"Site-directed mutagenesis / natural patient mutations, cell-free translocation assay with neutrophil membranes and cytosol, electron transfer assay in solubilized membranes","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 / Strong — natural missense mutations with cell-free reconstitution assay and electron transfer measurements; multiple functional domains dissected","pmids":["10627478"],"is_preprint":false},{"year":1991,"finding":"CCAAT displacement protein (CDP) functions as a transcriptional repressor of the gp91-phox (CYBB) gene. CDP binds the CCAAT-containing region of the proximal gp91-phox promoter, displacing CP1, and is present in nuclear extracts of non-expressing cells but absent/reduced in expressing cells. Deletion of the CDP/CP1-binding site from the promoter relieved repression; mutation of the CP1 site alone did not derepress, suggesting CDP represses through additional cis-elements.","method":"In vitro DNA-binding assays, nuclear extract analysis from expressing/non-expressing cells, promoter/reporter transfection assays with deletion and point mutations","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal correlation of CDP activity with CYBB expression across cell types, functional reporter assays with deletion and specific mutations confirming mechanism","pmids":["1885602"],"is_preprint":false},{"year":1998,"finding":"IFN-γ-induced transcription of gp91(phox) (CYBB) requires a multiprotein complex (HAF1/HAF1a) containing PU.1, IRF-1, and ICSBP binding to the proximal CYBB promoter. PU.1 with IRF-1 reconstitutes HAF1; PU.1 with all three factors reconstitutes HAF1a. Promoter activation requires serine 148-phosphorylated PU.1. PU.1 + IRF-1 + ICSBP together strongly activate CYBB transcription, much more than any pairwise combination.","method":"Electrophoretic mobility shift assay (EMSA), immunoprecipitation/cross-immunoreactivity, in vitro translation/reconstitution, transient co-transfection reporter assays in U937 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — EMSA reconstitution with in vitro translated factors, reporter co-transfection, phosphorylation site identification; multiple orthogonal methods","pmids":["9593745"],"is_preprint":false},{"year":2001,"finding":"SHP1 protein-tyrosine phosphatase inhibits gp91PHOX expression in undifferentiated myeloid cells by decreasing interaction of PU.1, IRF1, ICSBP, and CBP with the CYBB gene promoter. IRF1 and ICSBP are tyrosine-phosphorylated during IFN-γ-induced myeloid differentiation, and specific tyrosine residues in IRF1 and ICSBP are required for CYBB transcription. SHP1 thus antagonizes myeloid differentiation-stage-specific CYBB transcription by dephosphorylating these factors.","method":"Reporter gene assays, EMSA, co-immunoprecipitation, phosphorylation site mutagenesis, SHP1 overexpression/knockdown in myeloid cell lines","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional reporter assays with multiple transcription factors, phosphorylation site mutagenesis; single lab","pmids":["11483597"],"is_preprint":false},{"year":2002,"finding":"IFN-γ-induced CYBB transcription is mediated by cooperation of phosphorylated STAT-1α binding to a GAS element at -100 bp and IRF-1 binding to an ISRE at -88 bp of the gp91(phox) promoter. Site-directed mutagenesis of either element reduced IFN-γ-dependent transcription; both elements together are required for full induction.","method":"Transient expression assay with truncated/mutated reporters in U937 cells, EMSA with specific antibodies and GAS competitors, site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — site-directed mutagenesis of cis-elements combined with EMSA protein identification; two independent cis-elements functionally validated","pmids":["11781315"],"is_preprint":false},{"year":1995,"finding":"A hematopoietic-restricted cis-element in the proximal gp91-phox promoter (around -57 to -52 bp) binds a hematopoiesis-associated factor (HAF1) required for IFN-γ-induced gp91-phox transcription. Single base-pair mutations at -57, -55, -53, and -52 bp that abolish HAF1 binding are found in CGD patients and functionally reduce promoter activity.","method":"In vitro DNA-binding assays, promoter/reporter transfection assays, site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — functional validation of CGD patient mutations in reporter assays confirming mechanistic role; consistent with human genetics","pmids":["7713934"],"is_preprint":false},{"year":1999,"finding":"Elf-1 and PU.1 (Ets family transcription factors) bind the -57 to -52 bp element in the gp91(phox) promoter and trans-activate the proximal promoter. CGD mutations at -57 and -55 bp reduce binding affinity of both Elf-1 and PU.1 and diminish transactivation. No synergy was detected when both factors were coexpressed.","method":"EMSA, transient co-transfection reporter assays in HeLa and PLB985 cells, CGD mutation analysis","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA and reporter assays confirm binding and functional role; single lab","pmids":["10233904"],"is_preprint":false},{"year":1999,"finding":"YY1 binds five cis-elements in the gp91(phox) promoter and trans-activates the promoter in myeloid cells. YY1 antiserum disrupts BID complexes at all four BID-binding sites. Overexpression of YY1 activates a minimal promoter with two copies of the -145 bp binding site. YY1 competes with the repressor CDP for these binding sites during myeloid differentiation.","method":"Expression library screen, EMSA with antiserum, transient co-transfection reporter assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — library-based identification confirmed by EMSA and reporter assays; single lab, two methods","pmids":["10514482"],"is_preprint":false},{"year":2005,"finding":"HoxA9 activates CYBB transcription in differentiated myeloid cells via the same promoter cis-element repressed by HoxA10. HoxA9-mediated CYBB transcription requires Pbx1 co-factor and is inhibited by Meis1. Tyrosine phosphorylation of conserved HD residues increases HoxA9 binding to the CYBB promoter. The leukemia-associated Nup98-HoxA9 fusion protein blocks HoxA9-induced CYBB transcription by competing for the cis-element with phosphorylation-independent binding.","method":"Reporter gene assays, EMSA, co-immunoprecipitation, overexpression of HoxA9/Nup98-HoxA9/Pbx1/Meis1 in myeloid cell lines, phosphorylation site mutagenesis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assays and EMSA with multiple interacting factors; single lab","pmids":["15681849"],"is_preprint":false},{"year":2006,"finding":"SHP2 protein-tyrosine phosphatase dephosphorylates HoxA10, increasing HoxA10 binding to CYBB and NCF2 promoter cis-elements and thereby repressing gp91(PHOX) and p67(PHOX) expression. Constitutively active SHP2 mutants maintain persistent HoxA10-mediated CYBB repression during myelopoiesis, suggesting that activating SHP2 mutations cooperate with HoxA10 overexpression to block myeloid differentiation.","method":"Reporter gene assays, EMSA, co-immunoprecipitation, overexpression of SHP2 mutants in myeloid cell lines","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional reporter and EMSA showing phosphorylation-dependent mechanism; single lab","pmids":["17138561"],"is_preprint":false},{"year":2004,"finding":"JAK2 activation is necessary and sufficient for IFN-γ-induced CYBB transcription in phagocytic cells. JAK2 mediates ICSBP tyrosine phosphorylation (promoting ICSBP interaction with the HAF1 element) and HoxA10 tyrosine phosphorylation (abolishing HoxA10 repression of CYBB). Both events are downstream of JAK2 and together mediate IFN-γ-induced CYBB transcription.","method":"JAK2 inhibition/dominant-negative constructs, constitutively active JAK2 expression, EMSA, reporter gene assays in phagocytic cell lines","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function and loss-of-function JAK2 constructs with EMSA and reporter assays; single lab","pmids":["15496449"],"is_preprint":false},{"year":2000,"finding":"In coronary microvascular endothelial cells, gp91-phox and p22-phox are predominantly intracellular and colocalized in the vicinity of the endoplasmic reticulum, distinct from their plasma membrane/granule location in neutrophils. The endothelial gp91-phox sequence has differences in a putative NADPH-binding domain and putative glycosylation sites compared with phagocytic gp91-phox.","method":"cDNA cloning and sequence analysis, subcellular fractionation with immunoblotting, immunofluorescence colocalization in endothelial cells","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct subcellular fractionation and colocalization by immunofluorescence; single lab, two methods","pmids":["10938010"],"is_preprint":false},{"year":2006,"finding":"Nox2 and p22phox interact in endothelial cells as shown by bimolecular fluorescent complementation. NOX2 colocalizes with the ER marker calreticulin and with F-actin at the plasma membrane. NOX2 and NOX4, but not NOX1, contribute equally to endothelial ROS production and proliferation under basal conditions.","method":"Bimolecular fluorescent complementation, immunofluorescence colocalization, siRNA knockdown with ROS measurement and proliferation assay","journal":"Antioxidants & redox signaling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bimolecular fluorescent complementation for direct interaction, siRNA knockdown with functional readouts; single lab","pmids":["16987004"],"is_preprint":false},{"year":2006,"finding":"Nox2-derived ROS from endosomal compartments promote H2O2-dependent recruitment of TRAF6 to the IL-1R1/MyD88 endosomal complex, enabling IKK and NF-κB activation. Rac1 recruits Nox2 into the endosomal compartment independently of MyD88. MyD88-dependent endocytosis of IL-1R1 is required for the redox-dependent formation of the active signaling complex. Scavenging endosomal superoxide or H2O2 significantly abrogated IL-1β-dependent NF-κB activation.","method":"siRNA knockdown (Nox2, MyD88, Rac1), endosomal superoxide/H2O2 measurement, co-immunoprecipitation of endosomal complexes, NF-κB/IKK activation assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple siRNA knockdowns with co-IP of endosomal complexes and functional NF-κB readouts; multiple orthogonal methods replicated within one rigorous study","pmids":["16354686"],"is_preprint":false},{"year":2009,"finding":"NMDA receptor activation generates ROS in postsynaptic neurons through a NOX2-containing NADPH oxidase. The pathway involves nNOS → cGMP → PKG → NOX2 activation. In NOX2-knockout mice, NMDA-induced ROS increase was absent but the cerebral blood flow increase was preserved. Electron microscopy confirmed NOX2 immunolabeling in postsynaptic somata and dendrites co-expressing NMDA NR1 subunit and nNOS. In neuronal cultures, NMDA-induced ROS were blocked by NADPH oxidase inhibitors.","method":"In vivo NMDA application with ROS measurement, NOX2 knockout mice, electron microscopy immunolabeling, neuronal cultures with NADPH oxidase inhibitors, cGMP/PKG pathway inhibitors","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO mice with in vivo ROS measurement, EM localization, cell culture pharmacology; multiple orthogonal methods across in vivo and in vitro","pmids":["19244529"],"is_preprint":false},{"year":2017,"finding":"Nox2 forms a stable physical complex with TRPC3 channels in cardiomyocytes. Doxorubicin increases Nox2 protein levels and promotes TRPC3-Nox2 coupling, driving ROS overproduction and myocardial atrophy. Expression of a TRPC3 C-terminal minipeptide inhibiting TRPC3-Nox2 coupling suppressed doxorubicin-induced atrophy and LV dysfunction in mice.","method":"Co-immunoprecipitation (TRPC3-Nox2 complex), cardiomyocyte-specific dominant-negative minipeptide expression, ROS measurement, echocardiography, TRPC3-knockout mice","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 2 / Strong — co-IP of TRPC3-Nox2 complex confirmed, functional rescue with specific minipeptide, KO mice; multiple orthogonal methods","pmids":["28768915"],"is_preprint":false},{"year":2019,"finding":"In cardiomyocytes, ATP-induced Nox2 upregulation and ROS overproduction mediating atrophy depends on increased physical interaction between Nox2 and TRPC3. Knockdown of either TRPC3 or Nox2 suppressed nutritional deficiency-induced ATP release, ROS production, and cardiomyocyte atrophy, establishing a TRPC3-Nox2 axis as a key mediator.","method":"Co-immunoprecipitation, siRNA knockdown of TRPC3 and Nox2, ROS measurement, cardiomyocyte size assay","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP and dual knockdown with functional readouts; single lab, two methods","pmids":["31278358"],"is_preprint":false},{"year":2000,"finding":"In p67-phox-deficient CGD patients, both p67-phox and p40-phox are absent from cytosol. Reconstitution of NADPH oxidase activity requires dissociation of the p40-phox/p67-phox complex; p40-phox acts as a negative regulatory factor stabilizing the resting state by inhibiting p67-phox function. Adding recombinant p40-phox reversed p67-phox-mediated complementation in a dose-dependent manner in cell-free assays.","method":"Cell-free NADPH oxidase reconstitution assay with purified cytochrome b558, isolated cytosolic factors, recombinant p67-phox and p40-phox; B-cell line model","journal":"European journal of biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — cell-free reconstitution with purified components; dose-dependent effect of p40-phox; rigorous in vitro assay; single lab","pmids":["10672014"],"is_preprint":false},{"year":1996,"finding":"Retroviral transfer of human gp91phox (MSCV-h91Neo vector) into X-CGD PLB-985 cells fully reconstitutes respiratory burst oxidase activity in the majority of clones. Gene transfer into murine X-CGD bone marrow cells restored respiratory burst activity in granulocyte-monocyte progeny differentiated in vitro, demonstrating functional complementation of the enzymatic defect.","method":"Retroviral gene transfer, DHR/oxidative burst assay, Western blotting for gp91phox expression, in vitro granulocyte differentiation of murine bone marrow","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional reconstitution of oxidase activity by gene transfer in both human cell line and murine primary cells; single lab","pmids":["8781441"],"is_preprint":false},{"year":1996,"finding":"In X-CGD B-cell lines, mutations in gp91-phox lead to accumulation of an incompletely glycosylated gp91-phox precursor, similar to what is seen when p22-phox is absent. The affected mutations mapped to the FAD-binding domain, a potential heme-binding domain, and the region encoded by exon 3, delineating regions of gp91-phox important for biosynthesis and stable association with p22-phox.","method":"Western blotting of B-cell line lysates, identification of gp91-phox precursor species, mutation mapping","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Western blot in multiple patient-derived cell lines, consistent across mutations; single lab","pmids":["8615831"],"is_preprint":false},{"year":2017,"finding":"NOX2 (gp91phox) activity is down-regulated by ATM kinase-dependent phosphorylation at Ser486 within the NOX2 insertion sequence (NIS). PMA stimulation triggers Ser486 phosphorylation in purified cytochrome b558. ATM inhibition or Ser486Ala mutation enhanced NOX2 activity, while Ser486Glu mutation inhibited it. Deletion or exchange of NIS abolished both NADPH oxidase and reductase activity and impaired p47phox/p67phox phagosomal translocation.","method":"NOX2 chimera construction (NIS deletion/exchange), functional oxidase and reductase activity assays in PLB-985 cells, mass spectrometry phosphorylation mapping, ATM kinase inhibitor, Ser486Ala/Glu point mutations","journal":"Free radical biology & medicine","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro mutagenesis, MS phosphorylation site identification, functional assays with pharmacological and genetic validation; multiple methods in one study","pmids":["28916473"],"is_preprint":false},{"year":2021,"finding":"NOX2 oxidative burst results from a Rac-dependent feedforward autoactivation mechanism. Active Rac triggers NOX2 to produce O2-, which in turn activates redox-sensitive Rac, further activating NOX2 in a positive feedback loop. Mutagenesis-based kinetic analyses showed enzymatic Rac activation initiates the cycle, while redox-mediated Rac activation drives ~98% of NOX2 activation and accounts for the characteristic burst kinetics.","method":"Mutagenesis of Rac redox-sensitive residues, kinetic O2- production assays, cell-based ROS measurements, NOX2 reconstitution assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis combined with kinetic reconstitution assays and cell analyses; mechanistic dissection of feedforward loop","pmids":["34293347"],"is_preprint":false},{"year":2016,"finding":"Nox2 activation promotes thioredoxin-1 (TRX-1)/p40phox interaction in the cytosol, leading to nuclear exclusion of TRX-1. Conversely, genetic Nox2 deficiency or apocynin inhibition causes reductive stress with nuclear TRX-1 accumulation and NF-κB hyperactivation after LPS stimulation. This identifies a Nox2/TRX-1/NF-κB signaling pathway relevant to CGD-associated hyperinflammation.","method":"Co-immunoprecipitation (TRX-1/p40phox), nuclear fractionation, NF-κB reporter, Nox2 KO mice, apocynin pharmacology, primary CGD patient monocytes/neutrophils, TrxR-1 inhibitors","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP of TRX-1/p40phox, nuclear fractionation, confirmed in CGD patients; single lab but multiple methods and human validation","pmids":["27698473"],"is_preprint":false},{"year":2016,"finding":"NOX2/gp91phox contributes to RANKL-induced osteoclast differentiation by upregulating NFATc1. Mice deficient in gp91phox showed ~30% reduction in osteoclast differentiation, increased bone density, and impaired RANKL-induced NFATc1 expression. H2O2 treatment almost completely rescued osteoclast differentiation in gp91phox-/- bone marrow monocytes, establishing superoxide as a signaling intermediate upstream of NFATc1.","method":"gp91phox knockout mice, in vitro osteoclast differentiation assay, H2O2 rescue experiment, antioxidant/superoxide inhibitor treatment of wild-type BMMs, NFATc1 expression analysis","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mice with defined phenotype, H2O2 rescue and pharmacological inhibition identifying downstream mediator; single lab","pmids":["27897222"],"is_preprint":false},{"year":2014,"finding":"Lipid (palmitate)-induced Nox2 activation via PKCβII impairs lysosomal acidification and enzyme activity in cardiomyocytes through superoxide production, blocking autophagic flux. Inhibition of Nox2 prevented superoxide overproduction, restored lysosomal pH and enzyme activity, and reduced autophagosome accumulation.","method":"Nox2 siRNA knockdown and pharmacological inhibition in H9C2 cells, lysosomal pH measurement, lysosomal enzyme activity assay, PKCβII inhibitors, in vivo high-fat feeding model","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA and pharmacological inhibition with specific functional readouts (lysosomal pH, enzyme activity); single lab, multiple methods","pmids":["25529920"],"is_preprint":false},{"year":2019,"finding":"NOX2 suppression in leukemic stem cells (LSCs) collapses the self-renewal transcriptional program and activates myeloid differentiation programs. Downstream of NOX2, the forkhead transcription factor FOXC1 mediates this phenotype. Suppression of either NOX2 or FOXC1 induced differentiation of leukemic blasts and attenuated disease in xenotransplantation models of primary human myeloid leukemia.","method":"NOX2 knockout/knockdown in murine leukemia model, transcriptional analysis of purified LSCs, FOXC1 knockdown, xenotransplantation with primary human leukemia cells","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — murine KO model with transcriptional analysis and in vivo xenotransplantation; pathway placement via genetic epistasis; single lab","pmids":["30943405"],"is_preprint":false},{"year":2020,"finding":"CYBB/NOX2 in conventional dendritic cells (cDCs) regulates LC3-associated phagocytosis (LAP) of MOG antigen and supports MOG-antigen presentation to CD4+ T cells via MHC class II. Genetic ablation of Cybb specifically in cDCs reduced encephalitogenic TH cell recruitment into the CNS and ameliorated EAE upon adoptive transfer of MOG-specific CD4+ T cells, placing CYBB in the LAP-dependent antigen processing pathway.","method":"Conditional Cybb deletion in cDCs (cDC-specific Cybb KO), EAE adoptive transfer model, antigen presentation assay, LAP analysis","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with defined cellular pathway (LAP) and functional EAE model; single lab","pmids":["32401602"],"is_preprint":false},{"year":2018,"finding":"CYBB/NOX2 in glioblastoma cells interacts with Nrf2 and thereby regulates SOD2 transcription. TMZ-resistant GBM cells displayed CYBB/Nrf2/SOD2 axis activation maintaining high ROS state while conferring ferroptosis resistance. CYBB knockdown reduced erastin-mediated ferroptosis resistance in TMZ-resistant cells.","method":"Co-immunoprecipitation (CYBB-Nrf2), SOD2 expression after CYBB knockdown/overexpression, erastin ferroptosis assay, xenograft mouse model","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-IP of CYBB-Nrf2 interaction plus functional assays with knockdown; single lab","pmids":["37175412"],"is_preprint":false},{"year":2016,"finding":"Nox2-derived ROS mediate macrophage macropinocytosis via PI3K/Akt pathway and cofilin activation. PKC-dependent Nox2 activation generates intracellular superoxide that inhibits PTEN, activates PI3K/Akt, and activates cofilin-mediated actin reorganization promoting membrane ruffling and macropinosome formation. In vivo peritoneal chimera experiments showed reduced macropinocytotic lipid uptake in Nox2-deficient macrophages in hypercholesterolemic ApoE-/- mice.","method":"Nox2 siRNA knockdown, PKC inhibitors, intracellular superoxide scavenging, PI3K/Akt/cofilin activation assays, peritoneal chimera with Nox2y/- macrophages in ApoE-/- mice","journal":"Antioxidants & redox signaling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and pharmacological knockdown with defined pathway dissection and in vivo validation; single lab","pmids":["27488058"],"is_preprint":false},{"year":2019,"finding":"In zebrafish nox2/cybb mutants, retinal ganglion cell axons are mistargeted in the optic tectum and the ganglion cell layer is expanded, establishing a cell-autonomous role for Nox2/Cybb in retinotectal axonal connectivity and optic nerve formation.","method":"CRISPR/Cas9-generated nox2/cybb zebrafish mutants (chimeric and homozygous), pan-Nox inhibitor (celastrol) treatment, H2O2 rescue, cultured retinal ganglion cell neurite outgrowth assay with Nox inhibitors","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR KO zebrafish with specific neural connectivity phenotype and cell culture validation; single lab","pmids":["29793976"],"is_preprint":false},{"year":2021,"finding":"TAZ transcriptionally induces Cybb (encoding NOX2) in hepatocytes. Elevated NOX2 activity leads to NADPH oxidase-mediated oxidative DNA damage that promotes hepatocellular carcinoma development in NASH. shRNA silencing of Cybb or overexpression of DNA-repair enzymes (OGG1, NHEJ1) suppressed tumor formation in pre-tumor NASH mice. Correlation between TAZ, NOX2, and oxidative DNA damage was confirmed in human NASH-HCC non-tumor liver tissue.","method":"AAV8-H1-shCybb gene silencing in pre-tumor NASH mice, AAV8-TBG-OGG1/NHEJ1 rescue, 8-oxoguanine/DNA damage assays, transcriptional analysis","journal":"Journal of hepatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo shRNA silencing with DNA damage readout and multiple rescue approaches; single lab","pmids":["34902531"],"is_preprint":false},{"year":2003,"finding":"Neutrophil gp91phox-derived superoxide is the principal mechanism by which neutrophils cause muscle membrane lysis in vitro and in vivo. gp91phox null neutrophils failed to produce superoxide and caused significantly less muscle cell cytolysis in vitro. In vivo hindlimb reloading of gp91phox null mice showed 90% reduction in muscle fibre membrane injury despite unchanged neutrophil/macrophage infiltration.","method":"gp91phox null mutant mice, in vitro cytotoxicity assay (neutrophils vs. muscle cells), in vivo muscle reloading model with membrane lesion quantification (extracellular dye uptake), leukocyte counting","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO mice with both in vitro and in vivo functional readouts; confounded only by potential compensatory effects; clear mechanism with consistent results across models","pmids":["14555723"],"is_preprint":false},{"year":2017,"finding":"Targeted repair of CYBB exon 5 mutations by TALEN or Cas9-mediated exon replacement in X-CGD iPSCs restored gp91phox expression and ROS production in iPSC-derived granulocytes. Insertion of an exon 1-13 minigene at exon 1 failed to restore gp91phox expression, whereas insertion of an exon 2-13 minigene at exon 2 fully restored gp91phox and ROS activity. This demonstrated that intronic sequences in intron 1 are necessary for CYBB expression from the endogenous locus.","method":"TALEN and Cas9 gene editing in patient iPSCs, iPSC differentiation to granulocytes, gp91phox Western blot, oxidative burst/ROS assay","journal":"Molecular therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gene editing with functional reconstitution assays; demonstrates intron 1 regulatory requirement; single lab","pmids":["28153086"],"is_preprint":false}],"current_model":"CYBB (gp91phox/NOX2) encodes the catalytic, heme-binding transmembrane subunit of the phagocyte NADPH oxidase; it forms a 1:1 heterodimer with p22phox (cytochrome b558), binds two non-equivalent heme groups that mediate electron transfer from cytoplasmic NADPH through FAD to molecular oxygen generating superoxide, and assembles with cytosolic subunits (p47phox, p67phox, p40phox) and the GTPase Rac2 whose binding to the flavoprotein C-terminal domain is enhanced by PKC-mediated phosphorylation of NOX2 at Ser486 and is subject to feedback deactivation via ATM-kinase phosphorylation; its transcription in myeloid cells is controlled by a network of lineage-restricted factors (PU.1, Elf-1, ICSBP, IRF-1, YY1, STAT-1, HoxA9/HoxA10, JAK2) with CDP acting as a repressor, and it signals beyond antimicrobial killing by generating endosomal ROS that regulate IL-1R/NF-κB signaling (via TRAF6 recruitment), NMDA receptor-dependent neuronal ROS production, antigen processing (LAP) in dendritic cells, macrophage macropinocytosis via PI3K/cofilin, and cardiomyocyte function through a stable TRPC3-Nox2 complex."},"narrative":{"mechanistic_narrative":"CYBB (gp91phox/NOX2) encodes the catalytic, heme-binding transmembrane subunit of the phagocyte NADPH oxidase, the enzyme system that transfers electrons from cytoplasmic NADPH through FAD to molecular oxygen to generate superoxide [PMID:9653128, PMID:10627478]. gp91phox is the sole heme-binding subunit of flavocytochrome b558, carrying two non-equivalent heme groups, and assembles as a 1:1 heterodimer with p22phox, with both subunits required for stable biosynthesis and functional oxidase reconstitution with neutrophil cytosol [PMID:9653128, PMID:8527449, PMID:8615831]. Catalysis is governed by discrete residues in the FAD-binding domain that mediate hydride transfer from NADPH and by domains required for cytosolic subunit (p47phox/p67phox) translocation; missense mutations in these regions abolish electron transfer and underlie X-linked chronic granulomatous disease (X-CGD), which is corrected by restoring functional gp91phox expression [PMID:10627478, PMID:8781441, PMID:28153086]. Enzyme assembly and output are tuned by post-translational control: PKC phosphorylates the cytosolic flavoprotein domain to enhance diaphorase activity and binding of Rac2, p67phox, and p47phox [PMID:19028840], a Rac-dependent redox feedforward loop drives the characteristic oxidative burst kinetics [PMID:34293347], p40phox stabilizes the resting state as a negative regulator [PMID:10672014], and ATM-dependent phosphorylation at Ser486 within the NOX2 insertion sequence down-regulates activity [PMID:28916473]. CYBB transcription in myeloid cells is controlled by a lineage-restricted factor network — Ets factors PU.1 and Elf-1, IRF-1, ICSBP, STAT-1, YY1, and HoxA9 acting as activators, with CDP and HoxA10 as repressors — integrated through IFN-γ/JAK2 signaling and antagonized by the tyrosine phosphatases SHP1 and SHP2 [PMID:1885602, PMID:9593745, PMID:11781315, PMID:7713934, PMID:10233904, PMID:10514482, PMID:15681849, PMID:17138561, PMID:15496449]. Beyond antimicrobial superoxide production, NOX2-derived ROS act as a signaling output across cell types: they promote endosomal TRAF6 recruitment to drive IL-1R/NF-κB signaling [PMID:16354686], mediate NMDA-receptor-dependent neuronal ROS via an nNOS/cGMP/PKG pathway [PMID:19244529], support LC3-associated phagocytosis and MHC-II antigen presentation in dendritic cells [PMID:37175412], drive macrophage macropinocytosis through PI3K/Akt and cofilin [PMID:27488058], and form a stable TRPC3-Nox2 complex in cardiomyocytes that mediates stress-induced atrophy [PMID:28768915, PMID:31278358].","teleology":[{"year":1995,"claim":"Establishing the subunit architecture of cytochrome b558 was needed to define the core oxidase module; quantitative sequencing fixed the gp91phox:p22phox stoichiometry at 1:1.","evidence":"Affinity purification of native cytochrome b558 from neutrophil membranes with quantitative N-terminal sequencing","pmids":["8527449"],"confidence":"High","gaps":["Does not localize the heme groups or define the electron transfer path","Stoichiometry in non-phagocytic cells not addressed"]},{"year":1998,"claim":"It was unclear which subunit carried the redox cofactors; expression of gp91phox alone reconstituted the full b558 heme spectrum, proving gp91phox is the sole heme-binding catalytic subunit while both subunits are needed for superoxide production.","evidence":"Heterologous COS7 expression with spectral/redox titration and cell-free superoxide assay","pmids":["9653128"],"confidence":"High","gaps":["Atomic-resolution heme coordination not resolved","Mechanism of p22phox contribution to activity not defined"]},{"year":2000,"claim":"How specific residues control catalysis versus assembly was unknown; X-CGD missense mutations separated translocation-defective residues from a FAD-domain residue (Thr341) required for hydride transfer.","evidence":"Patient missense mutations analyzed by cell-free translocation and electron transfer assays in solubilized membranes","pmids":["10627478"],"confidence":"High","gaps":["Full structural basis of electron flow not mapped","Does not address regulatory phosphorylation"]},{"year":2000,"claim":"The resting-state control of the assembled oxidase was unclear; p40phox was shown to act as a negative regulator that must dissociate from p67phox for activity.","evidence":"Cell-free reconstitution with purified components and recombinant p40phox in p67phox-deficient CGD model","pmids":["10672014"],"confidence":"High","gaps":["In vivo dynamics of p40phox release not defined","Single-lab cell-free system"]},{"year":2008,"claim":"Post-translational activation of the catalytic subunit was poorly defined; PKC phosphorylation of the gp91phox cytosolic flavoprotein domain was shown to enhance diaphorase activity and cytosolic subunit binding.","evidence":"In vitro PKC phosphorylation of recombinant domain, 2D peptide mapping, binding and diaphorase assays with CGD controls","pmids":["19028840"],"confidence":"High","gaps":["Exact phosphosites within the domain not enumerated here","Quantitative contribution to cellular burst not established"]},{"year":2017,"claim":"A mechanism limiting oxidase output was unknown; ATM-dependent Ser486 phosphorylation within the NOX2 insertion sequence was identified as a deactivating modification, and the NIS itself was shown essential for activity and subunit translocation.","evidence":"NIS chimera/deletion, MS phosphosite mapping, Ser486 point mutants, ATM inhibitor in PLB-985 cells","pmids":["28916473"],"confidence":"High","gaps":["Physiological trigger linking ATM to NOX2 not fully defined","Structural role of NIS not resolved"]},{"year":2021,"claim":"The kinetics of the oxidative burst lacked a mechanistic explanation; a Rac-dependent redox feedforward loop was shown to account for ~98% of NOX2 activation.","evidence":"Mutagenesis of Rac redox-sensitive residues with kinetic O2- and cell-based ROS assays","pmids":["34293347"],"confidence":"High","gaps":["In vivo relevance across cell types not established","Identity of the redox sensor on Rac not fully defined"]},{"year":2005,"claim":"How CYBB transcription is restricted to mature myeloid cells and induced by IFN-γ was being assembled; a network of activators (PU.1, Elf-1, IRF-1, ICSBP, STAT-1, YY1, HoxA9) and repressors (CDP, HoxA10) acting on the proximal promoter, modulated by JAK2, SHP1, and SHP2, was defined.","evidence":"EMSA, reporter assays, reconstitution with in vitro translated factors, phosphosite mutagenesis, and phosphatase/kinase manipulation across myeloid cell lines (consolidated 1991–2006)","pmids":["1885602","7713934","9593745","10233904","10514482","11483597","11781315","15496449","15681849","17138561"],"confidence":"High","gaps":["Chromatin/epigenetic state of the locus not addressed in most studies","Relative in vivo contribution of each factor not weighted"]},{"year":2017,"claim":"Whether CYBB regulatory requirements extend beyond the promoter was unknown; gene-editing in X-CGD iPSCs showed that intron 1 sequences are necessary for endogenous CYBB expression and that exon repair restores ROS production.","evidence":"TALEN/Cas9 editing and minigene insertion in patient iPSCs with granulocyte differentiation and oxidative burst readouts","pmids":["28153086"],"confidence":"Medium","gaps":["Specific intron 1 regulatory element not mapped","Single-lab gene-editing study"]},{"year":2009,"claim":"Whether NOX2 functions as a signaling source rather than only an antimicrobial enzyme was unresolved; endosomal NOX2-derived ROS were shown to drive TRAF6 recruitment for IL-1R/NF-κB activation, and a NOX2/TRX-1/NF-κB axis links NOX2 to inflammatory control.","evidence":"siRNA knockdowns, endosomal ROS measurement, co-IP of signaling complexes and TRX-1/p40phox, NF-κB readouts, CGD patient cells (consolidated)","pmids":["16354686","27698473"],"confidence":"High","gaps":["Spatial source of ROS within endosomes not fully resolved","Generalizability across receptor systems untested"]},{"year":2009,"claim":"A neuronal NOX2 function was undefined; NMDA receptor activation was shown to generate postsynaptic ROS through a NOX2 oxidase acting downstream of nNOS/cGMP/PKG.","evidence":"In vivo NMDA application with ROS measurement in NOX2-KO mice, EM localization, neuronal culture pharmacology","pmids":["19244529"],"confidence":"High","gaps":["Downstream neuronal targets of ROS not identified","Behavioral consequences not addressed"]},{"year":2020,"claim":"Roles for CYBB in adaptive immunity and tissue remodeling were emerging; conditional and global studies placed CYBB in LC3-associated phagocytosis/antigen presentation, macrophage macropinocytosis, osteoclast differentiation, and neutrophil-mediated muscle injury.","evidence":"Conditional cDC Cybb KO with EAE transfer, Nox2 KO/siRNA with PI3K/cofilin and NFATc1 readouts, gp91phox-null muscle injury models (consolidated)","pmids":["32401602","27488058","27897222","14555723"],"confidence":"High","gaps":["Molecular ROS targets in each pathway only partially defined","Cell-type-specific regulation of NOX2 output not unified"]},{"year":2019,"claim":"Whether NOX2 acts through stable partner complexes in non-phagocytic tissues was unknown; a stable TRPC3-Nox2 complex was shown to mediate cardiomyocyte ROS overproduction and atrophy under doxorubicin and nutritional/ATP stress.","evidence":"Co-IP of TRPC3-Nox2, dominant-negative minipeptide, dual knockdown, ROS and atrophy assays, TRPC3-KO mice (consolidated)","pmids":["28768915","31278358"],"confidence":"High","gaps":["Structural basis of TRPC3-Nox2 coupling not resolved","Whether cytosolic subunits participate in this complex not defined"]},{"year":2021,"claim":"Pathogenic roles for NOX2-derived ROS in cancer and metabolic disease were emerging; CYBB was linked to TAZ-driven oxidative DNA damage in NASH-HCC, a CYBB/Nrf2/SOD2 ferroptosis-resistance axis in glioblastoma, and a NOX2/FOXC1 self-renewal program in leukemic stem cells.","evidence":"In vivo shCybb silencing with DNA-repair rescue, CYBB-Nrf2 co-IP with ferroptosis assays, NOX2/FOXC1 epistasis in leukemia xenografts (consolidated)","pmids":["34902531","37175412","30943405"],"confidence":"Medium","gaps":["Direct ROS targets driving each oncogenic phenotype not fully mapped","Single-lab studies for each context"]},{"year":null,"claim":"How NOX2 output is spatially and contextually channeled — selecting between antimicrobial killing, discrete redox signaling, and pathological ROS — across phagocytic and non-phagocytic cells remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking subcellular localization to functional output","Determinants of partner choice (e.g., TRPC3 vs cytosolic subunits) unknown","Atomic structure of the assembled active oxidase not described in this corpus"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,3,24]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[2,23]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,15]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[16]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[14,15]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[16,30,34]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[16,17,31]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[4,5,7,13]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[16,25]}],"complexes":["cytochrome b558 / NADPH oxidase (NOX2-p22phox-p47phox-p67phox-p40phox-Rac)","TRPC3-Nox2 complex"],"partners":["CYBA","NCF1","NCF2","NCF4","RAC2","TRPC3","TRAF6","NFE2L2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P04839","full_name":"NADPH oxidase 2","aliases":["CGD91-phox","Cytochrome b(558) subunit beta","Cytochrome b558 subunit beta","Cytochrome b-245 heavy chain","Heme-binding membrane glycoprotein gp91phox","Neutrophil cytochrome b 91 kDa polypeptide","Superoxide-generating NADPH oxidase heavy chain subunit","gp91-1","gp91-phox","p22 phagocyte B-cytochrome"],"length_aa":570,"mass_kda":65.3,"function":"Catalytic subunit of the phagocyte NADPH oxidase complex that mediates the transfer of electrons from cytosolic NADPH to O2 to produce the superoxide anion (O2(-)) (PubMed:15338276, PubMed:36241643, PubMed:36413210, PubMed:38355798). In the activated complex, electrons are first transferred from NADPH to flavin adenine dinucleotide (FAD) and subsequently transferred via two heme molecules to molecular oxygen, producing superoxide through an outer-sphere reaction (Probable) (PubMed:38355798). Activation of the NADPH oxidase complex is initiated by the assembly of cytosolic subunits of the NADPH oxidase complex with the core NADPH oxidase complex to form a complex at the plasma membrane or phagosomal membrane (PubMed:19028840, PubMed:38355798). This activation process is initiated by phosphorylation dependent binding of the cytosolic NCF1/p47-phox subunit to the C-terminus of CYBA/p22-phox (By similarity). NADPH oxidase complex assembly is impaired through interaction with NRROS (By similarity)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P04839/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CYBB","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CYBB","total_profiled":1310},"omim":[{"mim_id":"619558","title":"RAB39A, MEMBER RAS ONCOGENE FAMILY; RAB39A","url":"https://www.omim.org/entry/619558"},{"mim_id":"618334","title":"CYTOCHROME b(-254) CHAPERONE 1; CYBC1","url":"https://www.omim.org/entry/618334"},{"mim_id":"611256","title":"NADPH OXIDASE ORGANIZER 1; NOXO1","url":"https://www.omim.org/entry/611256"},{"mim_id":"611255","title":"NADPH OXIDASE ACTIVATOR 1; NOXA1","url":"https://www.omim.org/entry/611255"},{"mim_id":"608512","title":"NEUTROPHIL CYTOSOLIC FACTOR 1; NCF1","url":"https://www.omim.org/entry/608512"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"bone marrow","ntpm":150.2},{"tissue":"lymphoid tissue","ntpm":141.4}],"url":"https://www.proteinatlas.org/search/CYBB"},"hgnc":{"alias_symbol":["GP91-PHOX","NOX2","GP91PHOX","p91-PHOX"],"prev_symbol":["CGD"]},"alphafold":{"accession":"P04839","domains":[{"cath_id":"-","chopping":"12-173_227-286","consensus_level":"high","plddt":93.469,"start":12,"end":286},{"cath_id":"2.40.30.10","chopping":"295-366_384-390","consensus_level":"high","plddt":92.0884,"start":295,"end":390},{"cath_id":"3.40.50.80","chopping":"403-408_435-448_470-482_501-570","consensus_level":"medium","plddt":89.8135,"start":403,"end":570}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P04839","model_url":"https://alphafold.ebi.ac.uk/files/AF-P04839-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P04839-F1-predicted_aligned_error_v6.png","plddt_mean":90.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CYBB","jax_strain_url":"https://www.jax.org/strain/search?query=CYBB"},"sequence":{"accession":"P04839","fasta_url":"https://rest.uniprot.org/uniprotkb/P04839.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P04839/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P04839"}},"corpus_meta":[{"pmid":"11348997","id":"PMC_11348997","title":"Novel gp91(phox) homologues in vascular smooth muscle cells : nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways.","date":"2001","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/11348997","citation_count":720,"is_preprint":false},{"pmid":"11376945","id":"PMC_11376945","title":"Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5.","date":"2001","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/11376945","citation_count":681,"is_preprint":false},{"pmid":"12615943","id":"PMC_12615943","title":"Nicotiana benthamiana gp91phox homologs NbrbohA and NbrbohB participate in H2O2 accumulation and resistance to Phytophthora infestans.","date":"2003","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/12615943","citation_count":411,"is_preprint":false},{"pmid":"19372727","id":"PMC_19372727","title":"p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases.","date":"2009","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19372727","citation_count":349,"is_preprint":false},{"pmid":"15706079","id":"PMC_15706079","title":"Expression and localization of NOX2 and NOX4 in primary human endothelial cells.","date":"2005","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/15706079","citation_count":272,"is_preprint":false},{"pmid":"31641008","id":"PMC_31641008","title":"A TAZ-ANGPTL4-NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer.","date":"2019","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/31641008","citation_count":262,"is_preprint":false},{"pmid":"1885602","id":"PMC_1885602","title":"CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter.","date":"1991","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1885602","citation_count":234,"is_preprint":false},{"pmid":"15037533","id":"PMC_15037533","title":"gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension.","date":"2004","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/15037533","citation_count":211,"is_preprint":false},{"pmid":"16987004","id":"PMC_16987004","title":"NOX2 and NOX4 mediate proliferative response in endothelial cells.","date":"2006","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/16987004","citation_count":207,"is_preprint":false},{"pmid":"19244529","id":"PMC_19244529","title":"NMDA receptor activation increases free radical production through nitric oxide and NOX2.","date":"2009","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19244529","citation_count":207,"is_preprint":false},{"pmid":"10938010","id":"PMC_10938010","title":"Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells.","date":"2000","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10938010","citation_count":204,"is_preprint":false},{"pmid":"16354686","id":"PMC_16354686","title":"Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16354686","citation_count":192,"is_preprint":false},{"pmid":"9653128","id":"PMC_9653128","title":"Gp91(phox) is the heme binding subunit of the superoxide-generating NADPH oxidase.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9653128","citation_count":174,"is_preprint":false},{"pmid":"26888560","id":"PMC_26888560","title":"NOX2-dependent regulation of inflammation.","date":"2016","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/26888560","citation_count":173,"is_preprint":false},{"pmid":"21384410","id":"PMC_21384410","title":"The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice.","date":"2011","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/21384410","citation_count":172,"is_preprint":false},{"pmid":"20919938","id":"PMC_20919938","title":"NOX2 complex-derived ROS as immune regulators.","date":"2011","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/20919938","citation_count":161,"is_preprint":false},{"pmid":"20659322","id":"PMC_20659322","title":"Gp91phox (NOX2) in classically activated microglia exacerbates traumatic brain injury.","date":"2010","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/20659322","citation_count":157,"is_preprint":false},{"pmid":"11045958","id":"PMC_11045958","title":"Upregulation of p67(phox) and gp91(phox) in aortas from angiotensin II-infused mice.","date":"2000","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11045958","citation_count":151,"is_preprint":false},{"pmid":"31302569","id":"PMC_31302569","title":"The phagocyte NOX2 NADPH oxidase in microbial killing and cell signaling.","date":"2019","source":"Current opinion in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31302569","citation_count":147,"is_preprint":false},{"pmid":"9593745","id":"PMC_9593745","title":"PU.1, interferon regulatory factor 1, and interferon consensus sequence-binding protein cooperate to increase gp91(phox) expression.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9593745","citation_count":139,"is_preprint":false},{"pmid":"19028840","id":"PMC_19028840","title":"Regulation of the phagocyte NADPH oxidase activity: phosphorylation of gp91phox/NOX2 by protein kinase C enhances its diaphorase activity and binding to Rac2, p67phox, and p47phox.","date":"2008","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/19028840","citation_count":139,"is_preprint":false},{"pmid":"32738789","id":"PMC_32738789","title":"Nox2 activation in Covid-19.","date":"2020","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/32738789","citation_count":122,"is_preprint":false},{"pmid":"10974555","id":"PMC_10974555","title":"NADPH oxidase subunit, gp91(phox) homologue, preferentially expressed in human colon epithelial cells.","date":"2000","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10974555","citation_count":122,"is_preprint":false},{"pmid":"11386368","id":"PMC_11386368","title":"Induction of plant gp91 phox homolog by fungal cell wall, arachidonic acid, and salicylic acid in potato.","date":"2001","source":"Molecular plant-microbe interactions : MPMI","url":"https://pubmed.ncbi.nlm.nih.gov/11386368","citation_count":117,"is_preprint":false},{"pmid":"19805647","id":"PMC_19805647","title":"Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study.","date":"2009","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/19805647","citation_count":114,"is_preprint":false},{"pmid":"25529920","id":"PMC_25529920","title":"Lipid-induced NOX2 activation inhibits autophagic flux by impairing lysosomal enzyme activity.","date":"2014","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/25529920","citation_count":113,"is_preprint":false},{"pmid":"11243862","id":"PMC_11243862","title":"Expression of p22-phox and gp91-phox, essential components of NADPH oxidase, increases after myocardial infarction.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11243862","citation_count":100,"is_preprint":false},{"pmid":"18193341","id":"PMC_18193341","title":"Inflammatory manifestations in chronic granulomatous disease (CGD).","date":"2008","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18193341","citation_count":97,"is_preprint":false},{"pmid":"34217063","id":"PMC_34217063","title":"Nox2 impairs VEGF-A-induced angiogenesis in placenta via mitochondrial ROS-STAT3 pathway.","date":"2021","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/34217063","citation_count":96,"is_preprint":false},{"pmid":"15608216","id":"PMC_15608216","title":"The Candida Genome Database (CGD), a community resource for Candida albicans gene and protein information.","date":"2005","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/15608216","citation_count":95,"is_preprint":false},{"pmid":"12114322","id":"PMC_12114322","title":"Increased NADPH oxidase activity, gp91phox expression, and endothelium-dependent vasorelaxation during neointima formation in rabbits.","date":"2002","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/12114322","citation_count":80,"is_preprint":false},{"pmid":"30943405","id":"PMC_30943405","title":"The Hematopoietic Oxidase NOX2 Regulates Self-Renewal of Leukemic Stem Cells.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/30943405","citation_count":71,"is_preprint":false},{"pmid":"37379662","id":"PMC_37379662","title":"Unlocking the power of NOX2: A comprehensive review on its role in immune regulation.","date":"2023","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/37379662","citation_count":67,"is_preprint":false},{"pmid":"14504257","id":"PMC_14504257","title":"L-arginine reverses p47phox and gp91phox expression induced by high salt in Dahl rats.","date":"2003","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/14504257","citation_count":66,"is_preprint":false},{"pmid":"11781315","id":"PMC_11781315","title":"Cooperation of STAT-1 and IRF-1 in interferon-gamma-induced transcription of the gp91(phox) gene.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11781315","citation_count":65,"is_preprint":false},{"pmid":"22399808","id":"PMC_22399808","title":"The HIF1 target gene NOX2 promotes angiogenesis through urotensin-II.","date":"2012","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/22399808","citation_count":61,"is_preprint":false},{"pmid":"22083605","id":"PMC_22083605","title":"Inflammation and repeated infections in CGD: two sides of a coin.","date":"2011","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/22083605","citation_count":59,"is_preprint":false},{"pmid":"28768915","id":"PMC_28768915","title":"TRPC3-Nox2 complex mediates doxorubicin-induced myocardial atrophy.","date":"2017","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/28768915","citation_count":59,"is_preprint":false},{"pmid":"15681849","id":"PMC_15681849","title":"HOXA9 activates transcription of the gene encoding gp91Phox during myeloid differentiation.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15681849","citation_count":59,"is_preprint":false},{"pmid":"27113160","id":"PMC_27113160","title":"TSPO Finds NOX2 in Microglia for Redox Homeostasis.","date":"2016","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27113160","citation_count":58,"is_preprint":false},{"pmid":"27897222","id":"PMC_27897222","title":"NADPH oxidase gp91phox contributes to RANKL-induced osteoclast differentiation by upregulating NFATc1.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27897222","citation_count":57,"is_preprint":false},{"pmid":"14555723","id":"PMC_14555723","title":"Null mutation of gp91phox reduces muscle membrane lysis during muscle inflammation in mice.","date":"2003","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/14555723","citation_count":57,"is_preprint":false},{"pmid":"30270440","id":"PMC_30270440","title":"NOX2 in autoimmunity, tumor growth and metastasis.","date":"2018","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/30270440","citation_count":55,"is_preprint":false},{"pmid":"10672014","id":"PMC_10672014","title":"Complementation of NADPH oxidase in p67-phox-deficient CGD patients p67-phox/p40-phox interaction.","date":"2000","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10672014","citation_count":55,"is_preprint":false},{"pmid":"29526808","id":"PMC_29526808","title":"Association of NOX2 subunits genetic variants with autoimmune diseases.","date":"2018","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29526808","citation_count":53,"is_preprint":false},{"pmid":"11483597","id":"PMC_11483597","title":"SHP1 protein-tyrosine phosphatase inhibits gp91PHOX and p67PHOX expression by inhibiting interaction of PU.1, IRF1, interferon consensus sequence-binding protein, and CREB-binding protein with homologous Cis elements in the CYBB and NCF2 genes.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11483597","citation_count":53,"is_preprint":false},{"pmid":"24624929","id":"PMC_24624929","title":"Loss of NOX2 (gp91phox) prevents oxidative stress and progression to advanced heart failure.","date":"2014","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/24624929","citation_count":52,"is_preprint":false},{"pmid":"10914676","id":"PMC_10914676","title":"Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency.","date":"2000","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10914676","citation_count":52,"is_preprint":false},{"pmid":"33312338","id":"PMC_33312338","title":"NOX2-Derived Reactive Oxygen Species in Cancer.","date":"2020","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/33312338","citation_count":49,"is_preprint":false},{"pmid":"32401602","id":"PMC_32401602","title":"CYBB/NOX2 in conventional DCs controls T cell encephalitogenicity during neuroinflammation.","date":"2020","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/32401602","citation_count":48,"is_preprint":false},{"pmid":"23684565","id":"PMC_23684565","title":"Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock.","date":"2013","source":"Nitric oxide : biology and chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23684565","citation_count":48,"is_preprint":false},{"pmid":"21321580","id":"PMC_21321580","title":"Gp91(phox) contributes to the development of experimental inflammatory bowel disease.","date":"2011","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21321580","citation_count":48,"is_preprint":false},{"pmid":"28153086","id":"PMC_28153086","title":"Targeted Repair of CYBB in X-CGD iPSCs Requires Retention of Intronic Sequences for Expression and Functional Correction.","date":"2017","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/28153086","citation_count":46,"is_preprint":false},{"pmid":"8527449","id":"PMC_8527449","title":"Stoichiometry of p22-phox and gp91-phox in phagocyte cytochrome b558.","date":"1995","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8527449","citation_count":45,"is_preprint":false},{"pmid":"36870375","id":"PMC_36870375","title":"Activation of neuronal NADPH oxidase NOX2 promotes inflammatory neurodegeneration.","date":"2023","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36870375","citation_count":44,"is_preprint":false},{"pmid":"8781441","id":"PMC_8781441","title":"High-level reconstitution of respiratory burst activity in a human X-linked chronic granulomatous disease (X-CGD) cell line and correction of murine X-CGD bone marrow cells by retroviral-mediated gene transfer of human gp91phox.","date":"1996","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/8781441","citation_count":44,"is_preprint":false},{"pmid":"28600985","id":"PMC_28600985","title":"Nox2 contributes to hyperinsulinemia-induced redox imbalance and impaired vascular function.","date":"2017","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/28600985","citation_count":43,"is_preprint":false},{"pmid":"33712802","id":"PMC_33712802","title":"Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR/Cas9 with 53BP1 inhibition for enhanced homology-directed repair.","date":"2021","source":"Gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33712802","citation_count":43,"is_preprint":false},{"pmid":"7713934","id":"PMC_7713934","title":"Characterization of a gp91-phox promoter element that is required for interferon gamma-induced transcription.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7713934","citation_count":42,"is_preprint":false},{"pmid":"37175412","id":"PMC_37175412","title":"NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37175412","citation_count":40,"is_preprint":false},{"pmid":"27698473","id":"PMC_27698473","title":"Apocynin and Nox2 regulate NF-κB by modifying thioredoxin-1 redox-state.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27698473","citation_count":40,"is_preprint":false},{"pmid":"34902531","id":"PMC_34902531","title":"TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis.","date":"2021","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/34902531","citation_count":37,"is_preprint":false},{"pmid":"26104383","id":"PMC_26104383","title":"Nox2 is a mediator of ischemia reperfusion injury.","date":"2015","source":"American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons","url":"https://pubmed.ncbi.nlm.nih.gov/26104383","citation_count":37,"is_preprint":false},{"pmid":"37244286","id":"PMC_37244286","title":"Metformin inhibits ovarian granular cell pyroptosis through the miR-670-3p/NOX2/ROS pathway.","date":"2023","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/37244286","citation_count":36,"is_preprint":false},{"pmid":"17138561","id":"PMC_17138561","title":"Activation of SHP2 protein-tyrosine phosphatase increases HoxA10-induced repression of the genes encoding gp91(PHOX) and p67(PHOX).","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17138561","citation_count":36,"is_preprint":false},{"pmid":"21925195","id":"PMC_21925195","title":"Prodigiosin inhibits gp91(phox) and iNOS expression to protect mice against the oxidative/nitrosative brain injury induced by hypoxia-ischemia.","date":"2011","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21925195","citation_count":36,"is_preprint":false},{"pmid":"38460811","id":"PMC_38460811","title":"Nox2 inhibition reduces trophoblast ferroptosis in preeclampsia via the STAT3/GPX4 pathway.","date":"2024","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38460811","citation_count":35,"is_preprint":false},{"pmid":"33096235","id":"PMC_33096235","title":"Nobiletin alleviates high-fat diet-induced nonalcoholic fatty liver disease by modulating AdipoR1 and gp91phox expression in rats.","date":"2020","source":"The Journal of nutritional biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33096235","citation_count":35,"is_preprint":false},{"pmid":"24478191","id":"PMC_24478191","title":"Primary immunodeficiency caused by an exonized retroposed gene copy inserted in the CYBB gene.","date":"2014","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/24478191","citation_count":35,"is_preprint":false},{"pmid":"10627478","id":"PMC_10627478","title":"Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10627478","citation_count":35,"is_preprint":false},{"pmid":"30984416","id":"PMC_30984416","title":"Nox2-dependent Neuroinflammation in An EAE Model of Multiple Sclerosis.","date":"2019","source":"Translational neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30984416","citation_count":33,"is_preprint":false},{"pmid":"10233904","id":"PMC_10233904","title":"Elf-1 and PU.1 induce expression of gp91(phox) via a promoter element mutated in a subset of chronic granulomatous disease patients.","date":"1999","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10233904","citation_count":32,"is_preprint":false},{"pmid":"37268807","id":"PMC_37268807","title":"Complement C3 Enhances LPS-Elicited Neuroinflammation and Neurodegeneration Via the Mac1/NOX2 Pathway.","date":"2023","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/37268807","citation_count":31,"is_preprint":false},{"pmid":"30772113","id":"PMC_30772113","title":"Liraglutide prevents β-cell apoptosis via inactivation of NOX2 and its related signaling pathway.","date":"2019","source":"Journal of diabetes and its complications","url":"https://pubmed.ncbi.nlm.nih.gov/30772113","citation_count":30,"is_preprint":false},{"pmid":"30062795","id":"PMC_30062795","title":"Pulmonary metastatic colonisation and granulomas in NOX2-deficient mice.","date":"2018","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/30062795","citation_count":30,"is_preprint":false},{"pmid":"37764077","id":"PMC_37764077","title":"Chronic Granulomatous Disease (CGD): Commonly Associated Pathogens, Diagnosis and Treatment.","date":"2023","source":"Microorganisms","url":"https://pubmed.ncbi.nlm.nih.gov/37764077","citation_count":29,"is_preprint":false},{"pmid":"16647052","id":"PMC_16647052","title":"Superoxide auto-augments superoxide formation and upregulates gp91(phox) expression in porcine pulmonary artery endothelial cells: inhibition by iloprost.","date":"2006","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16647052","citation_count":29,"is_preprint":false},{"pmid":"10514482","id":"PMC_10514482","title":"YY1 binds five cis-elements and trans-activates the myeloid cell-restricted gp91(phox) promoter.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10514482","citation_count":29,"is_preprint":false},{"pmid":"15814300","id":"PMC_15814300","title":"Expression of NOX-I, gp91phox, p47phox and P67phox in the aorta segments above and below coarctation.","date":"2005","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/15814300","citation_count":28,"is_preprint":false},{"pmid":"23207695","id":"PMC_23207695","title":"Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicing.","date":"2012","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/23207695","citation_count":27,"is_preprint":false},{"pmid":"31278358","id":"PMC_31278358","title":"TRPC3-Nox2 axis mediates nutritional deficiency-induced cardiomyocyte atrophy.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31278358","citation_count":26,"is_preprint":false},{"pmid":"8615831","id":"PMC_8615831","title":"Detection of gp91-phox precursor protein in B-cell lines from patients with X-linked chronic granulomatous disease as an indicator for mutations impairing cytochrome b558 biosynthesis.","date":"1996","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/8615831","citation_count":26,"is_preprint":false},{"pmid":"37562003","id":"PMC_37562003","title":"Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD.","date":"2023","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/37562003","citation_count":25,"is_preprint":false},{"pmid":"30459931","id":"PMC_30459931","title":"NOX2 oxidase expressed in endosomes promotes cell proliferation and prostate tumour development.","date":"2018","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/30459931","citation_count":25,"is_preprint":false},{"pmid":"37277492","id":"PMC_37277492","title":"Activated SIRT1 contributes to DPT-induced glioma cell parthanatos by upregulation of NOX2 and NAT10.","date":"2023","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/37277492","citation_count":25,"is_preprint":false},{"pmid":"31338092","id":"PMC_31338092","title":"Nox2 Regulates Platelet Activation and NET Formation in the Lung.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31338092","citation_count":24,"is_preprint":false},{"pmid":"15496449","id":"PMC_15496449","title":"JAK2 is necessary and sufficient for interferon-gamma-induced transcription of the gene encoding gp91PHOX.","date":"2004","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/15496449","citation_count":24,"is_preprint":false},{"pmid":"26136341","id":"PMC_26136341","title":"A NOX2/Egr-1/Fyn pathway delineates new targets for TKI-resistant malignancies.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26136341","citation_count":24,"is_preprint":false},{"pmid":"30268520","id":"PMC_30268520","title":"Inhibition of phosphodiesterase 2 reverses gp91phox oxidase-mediated depression- and anxiety-like behavior.","date":"2018","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30268520","citation_count":23,"is_preprint":false},{"pmid":"27488058","id":"PMC_27488058","title":"Nox2-Mediated PI3K and Cofilin Activation Confers Alternate Redox Control of Macrophage Pinocytosis.","date":"2016","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/27488058","citation_count":23,"is_preprint":false},{"pmid":"38697489","id":"PMC_38697489","title":"Microglial gp91phox-mediated neuroinflammation and ferroptosis contributes to learning and memory deficits in rotenone-treated mice.","date":"2024","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38697489","citation_count":22,"is_preprint":false},{"pmid":"31349119","id":"PMC_31349119","title":"NOX2 mediates quiescent handling of dead cell remnants in phagocytes.","date":"2019","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/31349119","citation_count":22,"is_preprint":false},{"pmid":"25198009","id":"PMC_25198009","title":"Equol is neuroprotective during focal cerebral ischemia and reperfusion that involves p-Src and gp91(phox).","date":"2014","source":"Current neurovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/25198009","citation_count":22,"is_preprint":false},{"pmid":"34293347","id":"PMC_34293347","title":"Rac-dependent feedforward autoactivation of NOX2 leads to oxidative burst.","date":"2021","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34293347","citation_count":22,"is_preprint":false},{"pmid":"28916473","id":"PMC_28916473","title":"Down-regulation of NOX2 activity in phagocytes mediated by ATM-kinase dependent phosphorylation.","date":"2017","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28916473","citation_count":22,"is_preprint":false},{"pmid":"39638264","id":"PMC_39638264","title":"Spinal AT1R contributes to neuroinflammation and neuropathic pain via NOX2-dependent redox signaling in microglia.","date":"2024","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39638264","citation_count":21,"is_preprint":false},{"pmid":"12139950","id":"PMC_12139950","title":"CYBB mutation analysis in X-linked chronic granulomatous disease.","date":"2002","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/12139950","citation_count":21,"is_preprint":false},{"pmid":"23832701","id":"PMC_23832701","title":"Nox2 and Nox4 influence neonatal c-kit(+) cardiac precursor cell status and differentiation.","date":"2013","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23832701","citation_count":21,"is_preprint":false},{"pmid":"29793976","id":"PMC_29793976","title":"nox2/cybb Deficiency Affects Zebrafish Retinotectal Connectivity.","date":"2018","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/29793976","citation_count":20,"is_preprint":false},{"pmid":"28292946","id":"PMC_28292946","title":"NOX2-dependent immunosuppression in chronic myelomonocytic leukemia.","date":"2017","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/28292946","citation_count":20,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54845,"output_tokens":10446,"usd":0.160612,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20865,"output_tokens":5202,"usd":0.117188,"stage2_stop_reason":"end_turn"},"total_usd":0.2778,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"gp91(phox) is the sole heme-binding subunit of flavocytochrome b558. COS7 cells expressing gp91(phox) alone showed a b-type cytochrome spectrum identical to neutrophil flavocytochrome b558, with two heme groups at midpoint potentials of -264 and -233 mV. p22(phox) alone showed no heme spectrum. However, coexpression of both subunits was required to reconstitute O2- production with neutrophil cytosol, indicating both subunits are necessary for functional NADPH oxidase assembly.\",\n      \"method\": \"Transgenic COS7 cell expression, spectral analysis, redox titration, confocal microscopy, immunoblotting of subcellular fractions, cell-free superoxide production assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with spectral and redox titration plus mutagenesis-level subunit dissection; multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"9653128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"gp91-phox and p22-phox form a 1:1 stoichiometric heterodimer in cytochrome b558. Direct N-terminal peptide sequencing of affinity-purified cytochrome b558 from human neutrophil membranes yielded a p22-phox:gp91-phox amino acid ratio of 0.96 ± 0.05, consistent with a 1:1 stoichiometry.\",\n      \"method\": \"Affinity purification of cytochrome b558 from neutrophil membranes, direct N-terminal peptide sequencing with quantitative amino acid analysis\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct biochemical sequencing of purified native complex with quantitative analysis across 25 cycles and 8 amino acids\",\n      \"pmids\": [\"8527449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"gp91phox/NOX2 is phosphorylated by protein kinase C (PKC) in stimulated human neutrophils. PKC phosphorylates the cytosolic carboxy-terminal flavoprotein domain of gp91phox on the same peptides phosphorylated in intact cells. PKC phosphorylation enhances the diaphorase activity of the gp91phox flavoprotein domain and increases its binding to Rac2, p67phox, and p47phox, thereby enhancing NADPH oxidase complex assembly and catalytic activity.\",\n      \"method\": \"2D tryptic peptide mapping, in vitro PKC phosphorylation of recombinant gp91phox cytosolic domain, diaphorase activity assay, binding assays with Rac2/p67phox/p47phox, PKC inhibitor (GF109203X) in intact neutrophils, CGD patient controls\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro phosphorylation with recombinant domain, 2D peptide mapping, functional diaphorase assay, confirmed in intact cells with inhibitor and CGD patient negative controls; multiple orthogonal methods\",\n      \"pmids\": [\"19028840\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Four missense mutations in gp91phox (Cys369Arg, Gly408Glu, Glu568Lys, Thr341Lys) identified in X-CGD patients abolish NADPH oxidase activity. Mutations at residues 369, 408, and 568 strongly impaired translocation/binding of p47phox and p67phox to the membrane cytochrome b558 in stimulated neutrophils and cell-free translocation assay. The Thr341Lys substitution (in the FAD-binding domain) supported normal p47phox/p67phox translocation but abolished electron transfer, implicating this residue in hydride transfer from NADPH to FAD. All four substitutions eliminated electron transfer in solubilized plasma membranes.\",\n      \"method\": \"Site-directed mutagenesis / natural patient mutations, cell-free translocation assay with neutrophil membranes and cytosol, electron transfer assay in solubilized membranes\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — natural missense mutations with cell-free reconstitution assay and electron transfer measurements; multiple functional domains dissected\",\n      \"pmids\": [\"10627478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"CCAAT displacement protein (CDP) functions as a transcriptional repressor of the gp91-phox (CYBB) gene. CDP binds the CCAAT-containing region of the proximal gp91-phox promoter, displacing CP1, and is present in nuclear extracts of non-expressing cells but absent/reduced in expressing cells. Deletion of the CDP/CP1-binding site from the promoter relieved repression; mutation of the CP1 site alone did not derepress, suggesting CDP represses through additional cis-elements.\",\n      \"method\": \"In vitro DNA-binding assays, nuclear extract analysis from expressing/non-expressing cells, promoter/reporter transfection assays with deletion and point mutations\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal correlation of CDP activity with CYBB expression across cell types, functional reporter assays with deletion and specific mutations confirming mechanism\",\n      \"pmids\": [\"1885602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"IFN-γ-induced transcription of gp91(phox) (CYBB) requires a multiprotein complex (HAF1/HAF1a) containing PU.1, IRF-1, and ICSBP binding to the proximal CYBB promoter. PU.1 with IRF-1 reconstitutes HAF1; PU.1 with all three factors reconstitutes HAF1a. Promoter activation requires serine 148-phosphorylated PU.1. PU.1 + IRF-1 + ICSBP together strongly activate CYBB transcription, much more than any pairwise combination.\",\n      \"method\": \"Electrophoretic mobility shift assay (EMSA), immunoprecipitation/cross-immunoreactivity, in vitro translation/reconstitution, transient co-transfection reporter assays in U937 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — EMSA reconstitution with in vitro translated factors, reporter co-transfection, phosphorylation site identification; multiple orthogonal methods\",\n      \"pmids\": [\"9593745\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"SHP1 protein-tyrosine phosphatase inhibits gp91PHOX expression in undifferentiated myeloid cells by decreasing interaction of PU.1, IRF1, ICSBP, and CBP with the CYBB gene promoter. IRF1 and ICSBP are tyrosine-phosphorylated during IFN-γ-induced myeloid differentiation, and specific tyrosine residues in IRF1 and ICSBP are required for CYBB transcription. SHP1 thus antagonizes myeloid differentiation-stage-specific CYBB transcription by dephosphorylating these factors.\",\n      \"method\": \"Reporter gene assays, EMSA, co-immunoprecipitation, phosphorylation site mutagenesis, SHP1 overexpression/knockdown in myeloid cell lines\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional reporter assays with multiple transcription factors, phosphorylation site mutagenesis; single lab\",\n      \"pmids\": [\"11483597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"IFN-γ-induced CYBB transcription is mediated by cooperation of phosphorylated STAT-1α binding to a GAS element at -100 bp and IRF-1 binding to an ISRE at -88 bp of the gp91(phox) promoter. Site-directed mutagenesis of either element reduced IFN-γ-dependent transcription; both elements together are required for full induction.\",\n      \"method\": \"Transient expression assay with truncated/mutated reporters in U937 cells, EMSA with specific antibodies and GAS competitors, site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — site-directed mutagenesis of cis-elements combined with EMSA protein identification; two independent cis-elements functionally validated\",\n      \"pmids\": [\"11781315\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"A hematopoietic-restricted cis-element in the proximal gp91-phox promoter (around -57 to -52 bp) binds a hematopoiesis-associated factor (HAF1) required for IFN-γ-induced gp91-phox transcription. Single base-pair mutations at -57, -55, -53, and -52 bp that abolish HAF1 binding are found in CGD patients and functionally reduce promoter activity.\",\n      \"method\": \"In vitro DNA-binding assays, promoter/reporter transfection assays, site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — functional validation of CGD patient mutations in reporter assays confirming mechanistic role; consistent with human genetics\",\n      \"pmids\": [\"7713934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Elf-1 and PU.1 (Ets family transcription factors) bind the -57 to -52 bp element in the gp91(phox) promoter and trans-activate the proximal promoter. CGD mutations at -57 and -55 bp reduce binding affinity of both Elf-1 and PU.1 and diminish transactivation. No synergy was detected when both factors were coexpressed.\",\n      \"method\": \"EMSA, transient co-transfection reporter assays in HeLa and PLB985 cells, CGD mutation analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA and reporter assays confirm binding and functional role; single lab\",\n      \"pmids\": [\"10233904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"YY1 binds five cis-elements in the gp91(phox) promoter and trans-activates the promoter in myeloid cells. YY1 antiserum disrupts BID complexes at all four BID-binding sites. Overexpression of YY1 activates a minimal promoter with two copies of the -145 bp binding site. YY1 competes with the repressor CDP for these binding sites during myeloid differentiation.\",\n      \"method\": \"Expression library screen, EMSA with antiserum, transient co-transfection reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — library-based identification confirmed by EMSA and reporter assays; single lab, two methods\",\n      \"pmids\": [\"10514482\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HoxA9 activates CYBB transcription in differentiated myeloid cells via the same promoter cis-element repressed by HoxA10. HoxA9-mediated CYBB transcription requires Pbx1 co-factor and is inhibited by Meis1. Tyrosine phosphorylation of conserved HD residues increases HoxA9 binding to the CYBB promoter. The leukemia-associated Nup98-HoxA9 fusion protein blocks HoxA9-induced CYBB transcription by competing for the cis-element with phosphorylation-independent binding.\",\n      \"method\": \"Reporter gene assays, EMSA, co-immunoprecipitation, overexpression of HoxA9/Nup98-HoxA9/Pbx1/Meis1 in myeloid cell lines, phosphorylation site mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assays and EMSA with multiple interacting factors; single lab\",\n      \"pmids\": [\"15681849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SHP2 protein-tyrosine phosphatase dephosphorylates HoxA10, increasing HoxA10 binding to CYBB and NCF2 promoter cis-elements and thereby repressing gp91(PHOX) and p67(PHOX) expression. Constitutively active SHP2 mutants maintain persistent HoxA10-mediated CYBB repression during myelopoiesis, suggesting that activating SHP2 mutations cooperate with HoxA10 overexpression to block myeloid differentiation.\",\n      \"method\": \"Reporter gene assays, EMSA, co-immunoprecipitation, overexpression of SHP2 mutants in myeloid cell lines\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional reporter and EMSA showing phosphorylation-dependent mechanism; single lab\",\n      \"pmids\": [\"17138561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"JAK2 activation is necessary and sufficient for IFN-γ-induced CYBB transcription in phagocytic cells. JAK2 mediates ICSBP tyrosine phosphorylation (promoting ICSBP interaction with the HAF1 element) and HoxA10 tyrosine phosphorylation (abolishing HoxA10 repression of CYBB). Both events are downstream of JAK2 and together mediate IFN-γ-induced CYBB transcription.\",\n      \"method\": \"JAK2 inhibition/dominant-negative constructs, constitutively active JAK2 expression, EMSA, reporter gene assays in phagocytic cell lines\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function and loss-of-function JAK2 constructs with EMSA and reporter assays; single lab\",\n      \"pmids\": [\"15496449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"In coronary microvascular endothelial cells, gp91-phox and p22-phox are predominantly intracellular and colocalized in the vicinity of the endoplasmic reticulum, distinct from their plasma membrane/granule location in neutrophils. The endothelial gp91-phox sequence has differences in a putative NADPH-binding domain and putative glycosylation sites compared with phagocytic gp91-phox.\",\n      \"method\": \"cDNA cloning and sequence analysis, subcellular fractionation with immunoblotting, immunofluorescence colocalization in endothelial cells\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct subcellular fractionation and colocalization by immunofluorescence; single lab, two methods\",\n      \"pmids\": [\"10938010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Nox2 and p22phox interact in endothelial cells as shown by bimolecular fluorescent complementation. NOX2 colocalizes with the ER marker calreticulin and with F-actin at the plasma membrane. NOX2 and NOX4, but not NOX1, contribute equally to endothelial ROS production and proliferation under basal conditions.\",\n      \"method\": \"Bimolecular fluorescent complementation, immunofluorescence colocalization, siRNA knockdown with ROS measurement and proliferation assay\",\n      \"journal\": \"Antioxidants & redox signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bimolecular fluorescent complementation for direct interaction, siRNA knockdown with functional readouts; single lab\",\n      \"pmids\": [\"16987004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Nox2-derived ROS from endosomal compartments promote H2O2-dependent recruitment of TRAF6 to the IL-1R1/MyD88 endosomal complex, enabling IKK and NF-κB activation. Rac1 recruits Nox2 into the endosomal compartment independently of MyD88. MyD88-dependent endocytosis of IL-1R1 is required for the redox-dependent formation of the active signaling complex. Scavenging endosomal superoxide or H2O2 significantly abrogated IL-1β-dependent NF-κB activation.\",\n      \"method\": \"siRNA knockdown (Nox2, MyD88, Rac1), endosomal superoxide/H2O2 measurement, co-immunoprecipitation of endosomal complexes, NF-κB/IKK activation assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple siRNA knockdowns with co-IP of endosomal complexes and functional NF-κB readouts; multiple orthogonal methods replicated within one rigorous study\",\n      \"pmids\": [\"16354686\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NMDA receptor activation generates ROS in postsynaptic neurons through a NOX2-containing NADPH oxidase. The pathway involves nNOS → cGMP → PKG → NOX2 activation. In NOX2-knockout mice, NMDA-induced ROS increase was absent but the cerebral blood flow increase was preserved. Electron microscopy confirmed NOX2 immunolabeling in postsynaptic somata and dendrites co-expressing NMDA NR1 subunit and nNOS. In neuronal cultures, NMDA-induced ROS were blocked by NADPH oxidase inhibitors.\",\n      \"method\": \"In vivo NMDA application with ROS measurement, NOX2 knockout mice, electron microscopy immunolabeling, neuronal cultures with NADPH oxidase inhibitors, cGMP/PKG pathway inhibitors\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO mice with in vivo ROS measurement, EM localization, cell culture pharmacology; multiple orthogonal methods across in vivo and in vitro\",\n      \"pmids\": [\"19244529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Nox2 forms a stable physical complex with TRPC3 channels in cardiomyocytes. Doxorubicin increases Nox2 protein levels and promotes TRPC3-Nox2 coupling, driving ROS overproduction and myocardial atrophy. Expression of a TRPC3 C-terminal minipeptide inhibiting TRPC3-Nox2 coupling suppressed doxorubicin-induced atrophy and LV dysfunction in mice.\",\n      \"method\": \"Co-immunoprecipitation (TRPC3-Nox2 complex), cardiomyocyte-specific dominant-negative minipeptide expression, ROS measurement, echocardiography, TRPC3-knockout mice\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — co-IP of TRPC3-Nox2 complex confirmed, functional rescue with specific minipeptide, KO mice; multiple orthogonal methods\",\n      \"pmids\": [\"28768915\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In cardiomyocytes, ATP-induced Nox2 upregulation and ROS overproduction mediating atrophy depends on increased physical interaction between Nox2 and TRPC3. Knockdown of either TRPC3 or Nox2 suppressed nutritional deficiency-induced ATP release, ROS production, and cardiomyocyte atrophy, establishing a TRPC3-Nox2 axis as a key mediator.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown of TRPC3 and Nox2, ROS measurement, cardiomyocyte size assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP and dual knockdown with functional readouts; single lab, two methods\",\n      \"pmids\": [\"31278358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"In p67-phox-deficient CGD patients, both p67-phox and p40-phox are absent from cytosol. Reconstitution of NADPH oxidase activity requires dissociation of the p40-phox/p67-phox complex; p40-phox acts as a negative regulatory factor stabilizing the resting state by inhibiting p67-phox function. Adding recombinant p40-phox reversed p67-phox-mediated complementation in a dose-dependent manner in cell-free assays.\",\n      \"method\": \"Cell-free NADPH oxidase reconstitution assay with purified cytochrome b558, isolated cytosolic factors, recombinant p67-phox and p40-phox; B-cell line model\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cell-free reconstitution with purified components; dose-dependent effect of p40-phox; rigorous in vitro assay; single lab\",\n      \"pmids\": [\"10672014\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Retroviral transfer of human gp91phox (MSCV-h91Neo vector) into X-CGD PLB-985 cells fully reconstitutes respiratory burst oxidase activity in the majority of clones. Gene transfer into murine X-CGD bone marrow cells restored respiratory burst activity in granulocyte-monocyte progeny differentiated in vitro, demonstrating functional complementation of the enzymatic defect.\",\n      \"method\": \"Retroviral gene transfer, DHR/oxidative burst assay, Western blotting for gp91phox expression, in vitro granulocyte differentiation of murine bone marrow\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional reconstitution of oxidase activity by gene transfer in both human cell line and murine primary cells; single lab\",\n      \"pmids\": [\"8781441\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"In X-CGD B-cell lines, mutations in gp91-phox lead to accumulation of an incompletely glycosylated gp91-phox precursor, similar to what is seen when p22-phox is absent. The affected mutations mapped to the FAD-binding domain, a potential heme-binding domain, and the region encoded by exon 3, delineating regions of gp91-phox important for biosynthesis and stable association with p22-phox.\",\n      \"method\": \"Western blotting of B-cell line lysates, identification of gp91-phox precursor species, mutation mapping\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Western blot in multiple patient-derived cell lines, consistent across mutations; single lab\",\n      \"pmids\": [\"8615831\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NOX2 (gp91phox) activity is down-regulated by ATM kinase-dependent phosphorylation at Ser486 within the NOX2 insertion sequence (NIS). PMA stimulation triggers Ser486 phosphorylation in purified cytochrome b558. ATM inhibition or Ser486Ala mutation enhanced NOX2 activity, while Ser486Glu mutation inhibited it. Deletion or exchange of NIS abolished both NADPH oxidase and reductase activity and impaired p47phox/p67phox phagosomal translocation.\",\n      \"method\": \"NOX2 chimera construction (NIS deletion/exchange), functional oxidase and reductase activity assays in PLB-985 cells, mass spectrometry phosphorylation mapping, ATM kinase inhibitor, Ser486Ala/Glu point mutations\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro mutagenesis, MS phosphorylation site identification, functional assays with pharmacological and genetic validation; multiple methods in one study\",\n      \"pmids\": [\"28916473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NOX2 oxidative burst results from a Rac-dependent feedforward autoactivation mechanism. Active Rac triggers NOX2 to produce O2-, which in turn activates redox-sensitive Rac, further activating NOX2 in a positive feedback loop. Mutagenesis-based kinetic analyses showed enzymatic Rac activation initiates the cycle, while redox-mediated Rac activation drives ~98% of NOX2 activation and accounts for the characteristic burst kinetics.\",\n      \"method\": \"Mutagenesis of Rac redox-sensitive residues, kinetic O2- production assays, cell-based ROS measurements, NOX2 reconstitution assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis combined with kinetic reconstitution assays and cell analyses; mechanistic dissection of feedforward loop\",\n      \"pmids\": [\"34293347\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Nox2 activation promotes thioredoxin-1 (TRX-1)/p40phox interaction in the cytosol, leading to nuclear exclusion of TRX-1. Conversely, genetic Nox2 deficiency or apocynin inhibition causes reductive stress with nuclear TRX-1 accumulation and NF-κB hyperactivation after LPS stimulation. This identifies a Nox2/TRX-1/NF-κB signaling pathway relevant to CGD-associated hyperinflammation.\",\n      \"method\": \"Co-immunoprecipitation (TRX-1/p40phox), nuclear fractionation, NF-κB reporter, Nox2 KO mice, apocynin pharmacology, primary CGD patient monocytes/neutrophils, TrxR-1 inhibitors\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP of TRX-1/p40phox, nuclear fractionation, confirmed in CGD patients; single lab but multiple methods and human validation\",\n      \"pmids\": [\"27698473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NOX2/gp91phox contributes to RANKL-induced osteoclast differentiation by upregulating NFATc1. Mice deficient in gp91phox showed ~30% reduction in osteoclast differentiation, increased bone density, and impaired RANKL-induced NFATc1 expression. H2O2 treatment almost completely rescued osteoclast differentiation in gp91phox-/- bone marrow monocytes, establishing superoxide as a signaling intermediate upstream of NFATc1.\",\n      \"method\": \"gp91phox knockout mice, in vitro osteoclast differentiation assay, H2O2 rescue experiment, antioxidant/superoxide inhibitor treatment of wild-type BMMs, NFATc1 expression analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mice with defined phenotype, H2O2 rescue and pharmacological inhibition identifying downstream mediator; single lab\",\n      \"pmids\": [\"27897222\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Lipid (palmitate)-induced Nox2 activation via PKCβII impairs lysosomal acidification and enzyme activity in cardiomyocytes through superoxide production, blocking autophagic flux. Inhibition of Nox2 prevented superoxide overproduction, restored lysosomal pH and enzyme activity, and reduced autophagosome accumulation.\",\n      \"method\": \"Nox2 siRNA knockdown and pharmacological inhibition in H9C2 cells, lysosomal pH measurement, lysosomal enzyme activity assay, PKCβII inhibitors, in vivo high-fat feeding model\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA and pharmacological inhibition with specific functional readouts (lysosomal pH, enzyme activity); single lab, multiple methods\",\n      \"pmids\": [\"25529920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NOX2 suppression in leukemic stem cells (LSCs) collapses the self-renewal transcriptional program and activates myeloid differentiation programs. Downstream of NOX2, the forkhead transcription factor FOXC1 mediates this phenotype. Suppression of either NOX2 or FOXC1 induced differentiation of leukemic blasts and attenuated disease in xenotransplantation models of primary human myeloid leukemia.\",\n      \"method\": \"NOX2 knockout/knockdown in murine leukemia model, transcriptional analysis of purified LSCs, FOXC1 knockdown, xenotransplantation with primary human leukemia cells\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — murine KO model with transcriptional analysis and in vivo xenotransplantation; pathway placement via genetic epistasis; single lab\",\n      \"pmids\": [\"30943405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CYBB/NOX2 in conventional dendritic cells (cDCs) regulates LC3-associated phagocytosis (LAP) of MOG antigen and supports MOG-antigen presentation to CD4+ T cells via MHC class II. Genetic ablation of Cybb specifically in cDCs reduced encephalitogenic TH cell recruitment into the CNS and ameliorated EAE upon adoptive transfer of MOG-specific CD4+ T cells, placing CYBB in the LAP-dependent antigen processing pathway.\",\n      \"method\": \"Conditional Cybb deletion in cDCs (cDC-specific Cybb KO), EAE adoptive transfer model, antigen presentation assay, LAP analysis\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with defined cellular pathway (LAP) and functional EAE model; single lab\",\n      \"pmids\": [\"32401602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CYBB/NOX2 in glioblastoma cells interacts with Nrf2 and thereby regulates SOD2 transcription. TMZ-resistant GBM cells displayed CYBB/Nrf2/SOD2 axis activation maintaining high ROS state while conferring ferroptosis resistance. CYBB knockdown reduced erastin-mediated ferroptosis resistance in TMZ-resistant cells.\",\n      \"method\": \"Co-immunoprecipitation (CYBB-Nrf2), SOD2 expression after CYBB knockdown/overexpression, erastin ferroptosis assay, xenograft mouse model\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-IP of CYBB-Nrf2 interaction plus functional assays with knockdown; single lab\",\n      \"pmids\": [\"37175412\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Nox2-derived ROS mediate macrophage macropinocytosis via PI3K/Akt pathway and cofilin activation. PKC-dependent Nox2 activation generates intracellular superoxide that inhibits PTEN, activates PI3K/Akt, and activates cofilin-mediated actin reorganization promoting membrane ruffling and macropinosome formation. In vivo peritoneal chimera experiments showed reduced macropinocytotic lipid uptake in Nox2-deficient macrophages in hypercholesterolemic ApoE-/- mice.\",\n      \"method\": \"Nox2 siRNA knockdown, PKC inhibitors, intracellular superoxide scavenging, PI3K/Akt/cofilin activation assays, peritoneal chimera with Nox2y/- macrophages in ApoE-/- mice\",\n      \"journal\": \"Antioxidants & redox signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and pharmacological knockdown with defined pathway dissection and in vivo validation; single lab\",\n      \"pmids\": [\"27488058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In zebrafish nox2/cybb mutants, retinal ganglion cell axons are mistargeted in the optic tectum and the ganglion cell layer is expanded, establishing a cell-autonomous role for Nox2/Cybb in retinotectal axonal connectivity and optic nerve formation.\",\n      \"method\": \"CRISPR/Cas9-generated nox2/cybb zebrafish mutants (chimeric and homozygous), pan-Nox inhibitor (celastrol) treatment, H2O2 rescue, cultured retinal ganglion cell neurite outgrowth assay with Nox inhibitors\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR KO zebrafish with specific neural connectivity phenotype and cell culture validation; single lab\",\n      \"pmids\": [\"29793976\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TAZ transcriptionally induces Cybb (encoding NOX2) in hepatocytes. Elevated NOX2 activity leads to NADPH oxidase-mediated oxidative DNA damage that promotes hepatocellular carcinoma development in NASH. shRNA silencing of Cybb or overexpression of DNA-repair enzymes (OGG1, NHEJ1) suppressed tumor formation in pre-tumor NASH mice. Correlation between TAZ, NOX2, and oxidative DNA damage was confirmed in human NASH-HCC non-tumor liver tissue.\",\n      \"method\": \"AAV8-H1-shCybb gene silencing in pre-tumor NASH mice, AAV8-TBG-OGG1/NHEJ1 rescue, 8-oxoguanine/DNA damage assays, transcriptional analysis\",\n      \"journal\": \"Journal of hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo shRNA silencing with DNA damage readout and multiple rescue approaches; single lab\",\n      \"pmids\": [\"34902531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Neutrophil gp91phox-derived superoxide is the principal mechanism by which neutrophils cause muscle membrane lysis in vitro and in vivo. gp91phox null neutrophils failed to produce superoxide and caused significantly less muscle cell cytolysis in vitro. In vivo hindlimb reloading of gp91phox null mice showed 90% reduction in muscle fibre membrane injury despite unchanged neutrophil/macrophage infiltration.\",\n      \"method\": \"gp91phox null mutant mice, in vitro cytotoxicity assay (neutrophils vs. muscle cells), in vivo muscle reloading model with membrane lesion quantification (extracellular dye uptake), leukocyte counting\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO mice with both in vitro and in vivo functional readouts; confounded only by potential compensatory effects; clear mechanism with consistent results across models\",\n      \"pmids\": [\"14555723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Targeted repair of CYBB exon 5 mutations by TALEN or Cas9-mediated exon replacement in X-CGD iPSCs restored gp91phox expression and ROS production in iPSC-derived granulocytes. Insertion of an exon 1-13 minigene at exon 1 failed to restore gp91phox expression, whereas insertion of an exon 2-13 minigene at exon 2 fully restored gp91phox and ROS activity. This demonstrated that intronic sequences in intron 1 are necessary for CYBB expression from the endogenous locus.\",\n      \"method\": \"TALEN and Cas9 gene editing in patient iPSCs, iPSC differentiation to granulocytes, gp91phox Western blot, oxidative burst/ROS assay\",\n      \"journal\": \"Molecular therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gene editing with functional reconstitution assays; demonstrates intron 1 regulatory requirement; single lab\",\n      \"pmids\": [\"28153086\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CYBB (gp91phox/NOX2) encodes the catalytic, heme-binding transmembrane subunit of the phagocyte NADPH oxidase; it forms a 1:1 heterodimer with p22phox (cytochrome b558), binds two non-equivalent heme groups that mediate electron transfer from cytoplasmic NADPH through FAD to molecular oxygen generating superoxide, and assembles with cytosolic subunits (p47phox, p67phox, p40phox) and the GTPase Rac2 whose binding to the flavoprotein C-terminal domain is enhanced by PKC-mediated phosphorylation of NOX2 at Ser486 and is subject to feedback deactivation via ATM-kinase phosphorylation; its transcription in myeloid cells is controlled by a network of lineage-restricted factors (PU.1, Elf-1, ICSBP, IRF-1, YY1, STAT-1, HoxA9/HoxA10, JAK2) with CDP acting as a repressor, and it signals beyond antimicrobial killing by generating endosomal ROS that regulate IL-1R/NF-κB signaling (via TRAF6 recruitment), NMDA receptor-dependent neuronal ROS production, antigen processing (LAP) in dendritic cells, macrophage macropinocytosis via PI3K/cofilin, and cardiomyocyte function through a stable TRPC3-Nox2 complex.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CYBB (gp91phox/NOX2) encodes the catalytic, heme-binding transmembrane subunit of the phagocyte NADPH oxidase, the enzyme system that transfers electrons from cytoplasmic NADPH through FAD to molecular oxygen to generate superoxide [#0, #3]. gp91phox is the sole heme-binding subunit of flavocytochrome b558, carrying two non-equivalent heme groups, and assembles as a 1:1 heterodimer with p22phox, with both subunits required for stable biosynthesis and functional oxidase reconstitution with neutrophil cytosol [#0, #1, #22]. Catalysis is governed by discrete residues in the FAD-binding domain that mediate hydride transfer from NADPH and by domains required for cytosolic subunit (p47phox/p67phox) translocation; missense mutations in these regions abolish electron transfer and underlie X-linked chronic granulomatous disease (X-CGD), which is corrected by restoring functional gp91phox expression [#3, #21, #35]. Enzyme assembly and output are tuned by post-translational control: PKC phosphorylates the cytosolic flavoprotein domain to enhance diaphorase activity and binding of Rac2, p67phox, and p47phox [#2], a Rac-dependent redox feedforward loop drives the characteristic oxidative burst kinetics [#24], p40phox stabilizes the resting state as a negative regulator [#20], and ATM-dependent phosphorylation at Ser486 within the NOX2 insertion sequence down-regulates activity [#23]. CYBB transcription in myeloid cells is controlled by a lineage-restricted factor network — Ets factors PU.1 and Elf-1, IRF-1, ICSBP, STAT-1, YY1, and HoxA9 acting as activators, with CDP and HoxA10 as repressors — integrated through IFN-γ/JAK2 signaling and antagonized by the tyrosine phosphatases SHP1 and SHP2 [#4, #5, #7, #8, #9, #10, #11, #12, #13]. Beyond antimicrobial superoxide production, NOX2-derived ROS act as a signaling output across cell types: they promote endosomal TRAF6 recruitment to drive IL-1R/NF-κB signaling [#16], mediate NMDA-receptor-dependent neuronal ROS via an nNOS/cGMP/PKG pathway [#17], support LC3-associated phagocytosis and MHC-II antigen presentation in dendritic cells [#30], drive macrophage macropinocytosis through PI3K/Akt and cofilin [#31], and form a stable TRPC3-Nox2 complex in cardiomyocytes that mediates stress-induced atrophy [#18, #19].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Establishing the subunit architecture of cytochrome b558 was needed to define the core oxidase module; quantitative sequencing fixed the gp91phox:p22phox stoichiometry at 1:1.\",\n      \"evidence\": \"Affinity purification of native cytochrome b558 from neutrophil membranes with quantitative N-terminal sequencing\",\n      \"pmids\": [\"8527449\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not localize the heme groups or define the electron transfer path\", \"Stoichiometry in non-phagocytic cells not addressed\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"It was unclear which subunit carried the redox cofactors; expression of gp91phox alone reconstituted the full b558 heme spectrum, proving gp91phox is the sole heme-binding catalytic subunit while both subunits are needed for superoxide production.\",\n      \"evidence\": \"Heterologous COS7 expression with spectral/redox titration and cell-free superoxide assay\",\n      \"pmids\": [\"9653128\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution heme coordination not resolved\", \"Mechanism of p22phox contribution to activity not defined\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"How specific residues control catalysis versus assembly was unknown; X-CGD missense mutations separated translocation-defective residues from a FAD-domain residue (Thr341) required for hydride transfer.\",\n      \"evidence\": \"Patient missense mutations analyzed by cell-free translocation and electron transfer assays in solubilized membranes\",\n      \"pmids\": [\"10627478\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full structural basis of electron flow not mapped\", \"Does not address regulatory phosphorylation\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"The resting-state control of the assembled oxidase was unclear; p40phox was shown to act as a negative regulator that must dissociate from p67phox for activity.\",\n      \"evidence\": \"Cell-free reconstitution with purified components and recombinant p40phox in p67phox-deficient CGD model\",\n      \"pmids\": [\"10672014\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo dynamics of p40phox release not defined\", \"Single-lab cell-free system\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Post-translational activation of the catalytic subunit was poorly defined; PKC phosphorylation of the gp91phox cytosolic flavoprotein domain was shown to enhance diaphorase activity and cytosolic subunit binding.\",\n      \"evidence\": \"In vitro PKC phosphorylation of recombinant domain, 2D peptide mapping, binding and diaphorase assays with CGD controls\",\n      \"pmids\": [\"19028840\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Exact phosphosites within the domain not enumerated here\", \"Quantitative contribution to cellular burst not established\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"A mechanism limiting oxidase output was unknown; ATM-dependent Ser486 phosphorylation within the NOX2 insertion sequence was identified as a deactivating modification, and the NIS itself was shown essential for activity and subunit translocation.\",\n      \"evidence\": \"NIS chimera/deletion, MS phosphosite mapping, Ser486 point mutants, ATM inhibitor in PLB-985 cells\",\n      \"pmids\": [\"28916473\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological trigger linking ATM to NOX2 not fully defined\", \"Structural role of NIS not resolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"The kinetics of the oxidative burst lacked a mechanistic explanation; a Rac-dependent redox feedforward loop was shown to account for ~98% of NOX2 activation.\",\n      \"evidence\": \"Mutagenesis of Rac redox-sensitive residues with kinetic O2- and cell-based ROS assays\",\n      \"pmids\": [\"34293347\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance across cell types not established\", \"Identity of the redox sensor on Rac not fully defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"How CYBB transcription is restricted to mature myeloid cells and induced by IFN-γ was being assembled; a network of activators (PU.1, Elf-1, IRF-1, ICSBP, STAT-1, YY1, HoxA9) and repressors (CDP, HoxA10) acting on the proximal promoter, modulated by JAK2, SHP1, and SHP2, was defined.\",\n      \"evidence\": \"EMSA, reporter assays, reconstitution with in vitro translated factors, phosphosite mutagenesis, and phosphatase/kinase manipulation across myeloid cell lines (consolidated 1991–2006)\",\n      \"pmids\": [\"1885602\", \"7713934\", \"9593745\", \"10233904\", \"10514482\", \"11483597\", \"11781315\", \"15496449\", \"15681849\", \"17138561\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Chromatin/epigenetic state of the locus not addressed in most studies\", \"Relative in vivo contribution of each factor not weighted\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Whether CYBB regulatory requirements extend beyond the promoter was unknown; gene-editing in X-CGD iPSCs showed that intron 1 sequences are necessary for endogenous CYBB expression and that exon repair restores ROS production.\",\n      \"evidence\": \"TALEN/Cas9 editing and minigene insertion in patient iPSCs with granulocyte differentiation and oxidative burst readouts\",\n      \"pmids\": [\"28153086\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific intron 1 regulatory element not mapped\", \"Single-lab gene-editing study\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Whether NOX2 functions as a signaling source rather than only an antimicrobial enzyme was unresolved; endosomal NOX2-derived ROS were shown to drive TRAF6 recruitment for IL-1R/NF-κB activation, and a NOX2/TRX-1/NF-κB axis links NOX2 to inflammatory control.\",\n      \"evidence\": \"siRNA knockdowns, endosomal ROS measurement, co-IP of signaling complexes and TRX-1/p40phox, NF-κB readouts, CGD patient cells (consolidated)\",\n      \"pmids\": [\"16354686\", \"27698473\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Spatial source of ROS within endosomes not fully resolved\", \"Generalizability across receptor systems untested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"A neuronal NOX2 function was undefined; NMDA receptor activation was shown to generate postsynaptic ROS through a NOX2 oxidase acting downstream of nNOS/cGMP/PKG.\",\n      \"evidence\": \"In vivo NMDA application with ROS measurement in NOX2-KO mice, EM localization, neuronal culture pharmacology\",\n      \"pmids\": [\"19244529\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream neuronal targets of ROS not identified\", \"Behavioral consequences not addressed\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Roles for CYBB in adaptive immunity and tissue remodeling were emerging; conditional and global studies placed CYBB in LC3-associated phagocytosis/antigen presentation, macrophage macropinocytosis, osteoclast differentiation, and neutrophil-mediated muscle injury.\",\n      \"evidence\": \"Conditional cDC Cybb KO with EAE transfer, Nox2 KO/siRNA with PI3K/cofilin and NFATc1 readouts, gp91phox-null muscle injury models (consolidated)\",\n      \"pmids\": [\"32401602\", \"27488058\", \"27897222\", \"14555723\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular ROS targets in each pathway only partially defined\", \"Cell-type-specific regulation of NOX2 output not unified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Whether NOX2 acts through stable partner complexes in non-phagocytic tissues was unknown; a stable TRPC3-Nox2 complex was shown to mediate cardiomyocyte ROS overproduction and atrophy under doxorubicin and nutritional/ATP stress.\",\n      \"evidence\": \"Co-IP of TRPC3-Nox2, dominant-negative minipeptide, dual knockdown, ROS and atrophy assays, TRPC3-KO mice (consolidated)\",\n      \"pmids\": [\"28768915\", \"31278358\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of TRPC3-Nox2 coupling not resolved\", \"Whether cytosolic subunits participate in this complex not defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Pathogenic roles for NOX2-derived ROS in cancer and metabolic disease were emerging; CYBB was linked to TAZ-driven oxidative DNA damage in NASH-HCC, a CYBB/Nrf2/SOD2 ferroptosis-resistance axis in glioblastoma, and a NOX2/FOXC1 self-renewal program in leukemic stem cells.\",\n      \"evidence\": \"In vivo shCybb silencing with DNA-repair rescue, CYBB-Nrf2 co-IP with ferroptosis assays, NOX2/FOXC1 epistasis in leukemia xenografts (consolidated)\",\n      \"pmids\": [\"34902531\", \"37175412\", \"30943405\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ROS targets driving each oncogenic phenotype not fully mapped\", \"Single-lab studies for each context\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How NOX2 output is spatially and contextually channeled — selecting between antimicrobial killing, discrete redox signaling, and pathological ROS — across phagocytic and non-phagocytic cells remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking subcellular localization to functional output\", \"Determinants of partner choice (e.g., TRPC3 vs cytosolic subunits) unknown\", \"Atomic structure of the assembled active oxidase not described in this corpus\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 3, 24]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [2, 23]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 15]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [16]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [14, 15]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [16, 30, 34]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [16, 17, 31]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [4, 5, 7, 13]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [16, 25]}\n    ],\n    \"complexes\": [\"cytochrome b558 / NADPH oxidase (NOX2-p22phox-p47phox-p67phox-p40phox-Rac)\", \"TRPC3-Nox2 complex\"],\n    \"partners\": [\"CYBA\", \"NCF1\", \"NCF2\", \"NCF4\", \"RAC2\", \"TRPC3\", \"TRAF6\", \"NFE2L2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}